Palisade Bio (PALI) EBITDA Margin Growth (1y) (2012 - 2020)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 3,609.00 |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 1,536.00 |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -957.00 |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 8,807.00 |
| 10 | Palisade Bio | 439.25 Mn | 309.68 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2020 | -9.52 Mn |
| Sep 30, 2020 | -2.20 Mn |
| Jun 30, 2020 | -5.98 Mn |
| Mar 31, 2020 | -122,077.00 |
| Dec 31, 2019 | -6.86 Mn |
| Sep 30, 2019 | 252,640.00 |
| Jun 30, 2019 | -1.80 Mn |
| Mar 31, 2019 | -3.88 Mn |
| Dec 31, 2018 | -1.15 Mn |
| Sep 30, 2018 | -6.78 Mn |
| Jun 30, 2018 | 18.57 Mn |
| Mar 31, 2018 | 21.68 Mn |
| Dec 31, 2017 | 6.04 Mn |
| Sep 30, 2017 | 20.34 Mn |
| Jun 30, 2017 | -3.20 Mn |
| Mar 31, 2017 | -3.84 Mn |
| Dec 31, 2016 | 12.89 Mn |
| Sep 30, 2016 | 1.68 Mn |
| Jun 30, 2016 | 6.40 Mn |
| Mar 31, 2016 | -10.62 Mn |
| Dec 31, 2015 | -9.12 Mn |
| Sep 30, 2015 | -14.35 Mn |
| Jun 30, 2015 | -14.77 Mn |
| Mar 31, 2015 | -3.39 Mn |
| Dec 31, 2014 | 1.10 Mn |
| Sep 30, 2014 | 6.32 Mn |
| Jun 30, 2014 | 5.92 Mn |
| Mar 31, 2014 | -12.14 Mn |
| Dec 31, 2013 | -142,988.00 |
| Sep 30, 2013 | -14.38 Mn |
| Jun 30, 2013 | -12.64 Mn |
| Mar 31, 2013 | -124,479.00 |
| Dec 31, 2012 | -10.82 Mn |
| Sep 30, 2012 | 160,448.00 |